tetano
Editor, Senior Moderator
Front Immunol
. 2022 Oct 27;13:962079.
doi: 10.3389/fimmu.2022.962079. eCollection 2022.
CD8[SUP]+[/SUP] T-cell immune escape by SARS-CoV-2 variants of concern
Arnaud John Kombe Kombe[SUP] 1 [/SUP], Fleury Augustin Nsole Biteghe[SUP] 2 [/SUP], Zélia Nelly Ndoutoume[SUP] 3 [/SUP], Tengchuan Jin[SUP] 1 4 5 [/SUP]
Affiliations
Abstract
Despite the efficacy of antiviral drug repositioning, convalescent plasma (CP), and the currently available vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the worldwide coronavirus disease 2019 (COVID-19) pandemic is still challenging because of the ongoing emergence of certain new SARS-CoV-2 strains known as variants of concern (VOCs). Mutations occurring within the viral genome, characterized by these new emerging VOCs, confer on them the ability to efficiently resist and escape natural and vaccine-induced humoral and cellular immune responses. Consequently, these VOCs have enhanced infectivity, increasing their stable spread in a given population with an important fatality rate. While the humoral immune escape process is well documented, the evasion mechanisms of VOCs from cellular immunity are not well elaborated. In this review, we discussed how SARS-CoV-2 VOCs adapt inside host cells and escape anti-COVID-19 cellular immunity, focusing on the effect of specific SARS-CoV-2 mutations in hampering the activation of CD8[SUP]+[/SUP] T-cell immunity.
Keywords: CD8 + T-cell epitope; HLA; SARS-CoV-2; cellular immunity; cytotoxic T lymphocytes (CTL); immune escape; protein mutation; variant of concern (VOC).
. 2022 Oct 27;13:962079.
doi: 10.3389/fimmu.2022.962079. eCollection 2022.
CD8[SUP]+[/SUP] T-cell immune escape by SARS-CoV-2 variants of concern
Arnaud John Kombe Kombe[SUP] 1 [/SUP], Fleury Augustin Nsole Biteghe[SUP] 2 [/SUP], Zélia Nelly Ndoutoume[SUP] 3 [/SUP], Tengchuan Jin[SUP] 1 4 5 [/SUP]
Affiliations
- PMID: 36389664
- PMCID: PMC9647062
- DOI: 10.3389/fimmu.2022.962079
Abstract
Despite the efficacy of antiviral drug repositioning, convalescent plasma (CP), and the currently available vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the worldwide coronavirus disease 2019 (COVID-19) pandemic is still challenging because of the ongoing emergence of certain new SARS-CoV-2 strains known as variants of concern (VOCs). Mutations occurring within the viral genome, characterized by these new emerging VOCs, confer on them the ability to efficiently resist and escape natural and vaccine-induced humoral and cellular immune responses. Consequently, these VOCs have enhanced infectivity, increasing their stable spread in a given population with an important fatality rate. While the humoral immune escape process is well documented, the evasion mechanisms of VOCs from cellular immunity are not well elaborated. In this review, we discussed how SARS-CoV-2 VOCs adapt inside host cells and escape anti-COVID-19 cellular immunity, focusing on the effect of specific SARS-CoV-2 mutations in hampering the activation of CD8[SUP]+[/SUP] T-cell immunity.
Keywords: CD8 + T-cell epitope; HLA; SARS-CoV-2; cellular immunity; cytotoxic T lymphocytes (CTL); immune escape; protein mutation; variant of concern (VOC).
